A prototype axial shield for use in 3D whole-body PET

Citation
Pd. Cutler et R. Laforest, A prototype axial shield for use in 3D whole-body PET, IEEE NUCL S, 48(1), 2001, pp. 10-15
Citations number
9
Categorie Soggetti
Apllied Physucs/Condensed Matter/Materiales Science","Nuclear Emgineering
Journal title
IEEE TRANSACTIONS ON NUCLEAR SCIENCE
ISSN journal
00189499 → ACNP
Volume
48
Issue
1
Year of publication
2001
Part
1
Pages
10 - 15
Database
ISI
SICI code
0018-9499(200102)48:1<10:APASFU>2.0.ZU;2-1
Abstract
In 3D PET measurements, activity outside of the direct field-of-view (FOV) is known to degrade signal-to-noise within the direct FOV, primarily by inc reasing the overall rate of random coincidences. In 3D brain studies, addit ional shielding around the patient has been used to address this issue. The additional shielding limits the acceptance of single-photons arising from regions just above and below the direct FOV, the singles FOV, and thereby r educes the randoms measured by the tomograph. In this work, we extend this idea for use in the torso with a shielding configuration consisting of two "clam-shell" shields of lead surrounding the patient both above and below t he axial FOV. The lead is 6 mm thick by 10 or 20 cm in axial length, and cu rved into a C-shape to fit around the phantom or the patient's torso. The t op half of the clam-shell rests on plastic wheels which travel on rails mou nted to the edge of the patient pallet, and the separate lower half of each shield rests on a Styrofoam support beneath the bed. The shields are place d just above and below the direct field of view and as close to the patient as possible. Noise Equivalent Count (NEC) curves were measured with and wi thout shields in place around an axially long cylindrical phantom. The NEC rates from 2D and 3D patient studies were calculated and compared with the phantom-derived NEC curves to determine the effectiveness of the axial shie lds. We find that the additional shielding offers a small improvement in ph antom NEC at the high end of the nominal activity range for whole body FDG studies. 3D acquisition in two patients produces an NEC advantage of approx imately a factor of two. With the addition of an axial shield, there may be a small additional improvement at the high end of this activity range.